Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy

Mineralocorticoid receptor antagonists in chronic central serous chorioretinopathy

INTRODUCCIÓN La coriorretinopatía central serosa consiste en la filtración de fluido desde la coroides y su acumulación en el espacio subretinal. Su forma crónica se asocia a pérdida visual permanente. Los antagonistas de mineralocorticoides son una alternativa de tratamiento para esta patología, a...

Full description

Bibliographic Details
Main Authors:	Ana Sanhueza, Raúl González
Format:	Article
Language:	English
Published:	Medwave Estudios Limitada 2020-09-01
Series:	Medwave
Subjects:	central serous chorioretinopathy mineralocorticoid receptor antagonists eplerenone spironolactone epistemonikos grade
Online Access:	https://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/8036.act

Similar Items

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
by: Hamid-Reza Moein, et al.
Published: (2019-09-01)

Eplerenone versus placebo for chronic central serous chorioretinopathy: the VICI RCT
by: Andrew Lotery, et al.
Published: (2021-01-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
by: Yugar-Toledo JC, et al.
Published: (2017-10-01)

Spironolactone as an Adjunctive Treatment in Neovascular Age-Related Macular Degeneration
by: Kapil G. Kapoor, et al.
Published: (2017-05-01)

Oral eplerenone for the management of chronic central serous chorioretinopathy
by: Rishi P Singh, et al.
Published: (2015-04-01)

Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
by: Nina Vodošek Hojs, et al.
Published: (2021-06-01)

Management of chronic central serous chorioretinopathy
by: Daren Hanumunthadu, et al.
Published: (2018-01-01)

Spironolactone for Secondary Central Serous Chorioretinopathy: A Challenge-Rechallenge Case
by: Kapil G. Kapoor, et al.
Published: (2017-07-01)

Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
by: Katrin Fasler, et al.
Published: (2021-05-01)

Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review
by: Francesco Sartini, et al.
Published: (2020-08-01)

Mineralocorticoid receptor gene-2G/C polymorphism in central serous chorioretinopathy and relation of polymorphism with plasma cortisol levels
by: Alper Yazici, et al.
Published: (2016-07-01)

An unusual case of multifocal central serous chorioretinopathy with low serum cortisol managed using eplerenone
by: Kanika Aggarwal, et al.
Published: (2019-01-01)

Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone – a case report
by: Ramesh Venkatesh, et al.
Published: (2020-06-01)

Oral eplerenone for treatment of bullous retinal detachment secondary to chronic central serous retinopathy
by: Prachi Abhishek Dave, et al.
Published: (2017-01-01)

Oral Eplerenone Versus Observation in the Management of Acute Central Serous Chorioretinopathy: A Prospective, Randomized Comparative Study
by: Ramesh Venkatesh, et al.
Published: (2020-07-01)

Atypical chronic central serous chorioretinopathy with cystoid macular edema: Therapeutic response to medical and laser therapy
by: Jiun L. Do, et al.
Published: (2017-06-01)

Central Serous Chorioretinopathy: Pathogenesis and Management
by: Semeraro F, et al.
Published: (2019-12-01)

Visual and anatomical outcomes of spironolactone therapy in patients with chronic central serous chorioretinopathy
by: Khalil Ghasemi Falavarjani, et al.
Published: (2017-01-01)

Oral Spironolactone versus Conservative Treatment for Non-Resolving Central Serous Chorioretinopathy in Real-Life Practice
by: Sinawat S, et al.
Published: (2020-06-01)

Photodynamic Therapy with Verteporfin for Chronic Central Serous Chorioretinopathy: A Review of Data and Efficacy
by: Pierluigi Iacono, et al.
Published: (2020-10-01)

MINERALOCORTICOID ANTAGONISM: SELECTIVENESS GIVES MORE OPPORTUNITIES FOR HEART FAILURE MANAGEMENT
by: V. N. Soboleva, et al.
Published: (2015-01-01)

Central serous chorioretinopathy case with ooze sign
by: Mehmet Murat, et al.
Published: (2013-12-01)

Central Serous Chorioretinopathy Classification
by: Manuel Vilela, et al.
Published: (2021-12-01)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
by: Nappi J, et al.
Published: (2011-06-01)

Traumatic central serous chorioretinopathy
by: Laura Steeples, et al.
Published: (2015-01-01)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
by: Irini Chatziralli, et al.
Published: (2018-09-01)

Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury
by: J. Spencer Hauck, et al.
Published: (2019-10-01)

Delayed dark adaptation in central serous chorioretinopathy
by: Archana Nigalye, et al.
Published: (2021-06-01)

Central Serous Chorioretinopathy Mistaken for Tuberculous Choroiditis
by: Marina Papadia, et al.
Published: (2011-01-01)

Treatment of central serous chorioretinopathy with beta-blocker metipranolol
by: Oldrich Chrapek, et al.
Published: (2015-03-01)

Acute bilateral central serous chorioretinopathy following intra-articular injection of corticosteroid
by: Mondal Lakshmi, et al.
Published: (2005-01-01)

High-dose antioxidants for central serous chorioretinopathy; The randomized placebo-controlled study
by: Ratanasukon Mansing, et al.
Published: (2012-07-01)

Mineralocorticoid Receptor Antagonists
by: Ilaria Spoletini, et al.
Published: (2019-01-01)

Central serous chorioretinopathy following ingestion of sildenafil citrate
by: Mohammadpour M, et al.
Published: (2019-07-01)

Central Serous Chorioretinopathy in a Case of Regressed Familial Retinoblastoma
by: Saeed Karimi, et al.
Published: (2020-10-01)

The clinical research of central serous chorioretinopathy by multifocal electro- retinography
by: Qin Ye, et al.
Published: (2013-07-01)

Endogenous Hypercortisolism in recurrent Central Serous Chorioretinopathy
by: Sushmita Mukherji, et al.
Published: (2021-02-01)

Effects of propranolol in patients with central serous chorioretinopathy
by: Farzan Kianersi, et al.
Published: (2008-06-01)

Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy
by: Enrico Borrelli, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_2m6p6u1p8rjedkhqp4isovbhpv